Research programme: TRPM7 ion channel inhibitors - NoNO

Drug Profile

Research programme: TRPM7 ion channel inhibitors - NoNO

Alternative Names: TRPM7 inhibitors - NaNO

Latest Information Update: 26 Oct 2016

Price : $50

At a glance

  • Originator NoNO
  • Class Anti-ischaemics
  • Mechanism of Action TRPM cation channel inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Glaucoma; Myocardial ischaemia
  • Research Ischaemia

Most Recent Events

  • 26 Oct 2016 Early research in Ischaemia in Canada (unspecified route)
  • 26 Oct 2016 Preclinical trials in Glaucoma in Canada (unspecified route)
  • 26 Oct 2016 Preclinical trials in Myocardial ischaemia in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top